Cargando…

A Novel Non-invasive Model Based on GPR for the Prediction of Liver Fibrosis in Patients With Chronic Hepatitis B

Background: Some controversy remains regarding conventional serum indices for the evaluation of liver fibrosis. Therefore, we aimed to combine the existing index with other serum parameters to discriminate liver fibrosis stages in patients with chronic hepatitis B (CHB). Methods: A total of 1,622 tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Rongrong, Lu, Wei, Zhou, Xinlan, Huang, Dan, Wang, Yanbing, Li, Xiufen, Yan, Li, Lin, Weijia, Song, Shu, Zhang, Zhanqing, Chen, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495242/ https://www.ncbi.nlm.nih.gov/pubmed/34631748 http://dx.doi.org/10.3389/fmed.2021.727706

Ejemplares similares

Predictive Performances of Blood Parameter Ratios for Liver Inflammation and Advanced Liver Fibrosis in Chronic Hepatitis B Infection
por: Ding, Rongrong, et al.
Publicado: (2021)

Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease
por: Ding, Rongrong, et al.
Publicado: (2021)

Predictive performance of eLIFT for liver inflammation and fibrosis in chronic liver diseases
por: Yang, Zongguo, et al.
Publicado: (2021)

INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B
por: Ding, Rongrong, et al.
Publicado: (2021)

Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection
por: Zhang, Zhanqing, et al.
Publicado: (2022)

Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19
por: Ding, Rongrong, et al.
Publicado: (2021)

DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway
por: Ding, Rongrong, et al.
Publicado: (2021)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

An update on animal models of liver fibrosis
por: Wu, ShuTing, et al.
Publicado: (2023)

Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection
por: Zhang, Zhanqing, et al.
Publicado: (2021)

Hepatic and portal vein Doppler ultrasounds in assessing liver inflammation and fibrosis in chronic HBV infection with a normal ALT level
por: Tian, Li, et al.
Publicado: (2023)

The association between liver fibrosis scores and chronic kidney disease
por: Xiong, Shengjun, et al.
Publicado: (2023)

Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia
por: Hu, Qiankun, et al.
Publicado: (2022)

MTHFR rs1801133 Polymorphism Is Associated With Liver Fibrosis Progression in Chronic Hepatitis C: A Retrospective Study
por: Pineda-Tenor, Daniel, et al.
Publicado: (2020)

Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35
por: Kim, Mi-Jeong, et al.
Publicado: (2020)

A Non-invasive Model for Predicting Liver Inflammation in Chronic Hepatitis B Patients With Normal Serum Alanine Aminotransferase Levels
por: Li, Xiaoke, et al.
Publicado: (2021)

Direct-Acting Antiviral Treatment in Albanian Patients With Chronic Hepatitis C and Advanced Liver Fibrosis
por: Cuko, Liri, et al.
Publicado: (2022)

A Generic Nomogram Predicting the Stage of Liver Fibrosis Based on Serum Biochemical Indicators Among Chronic Hepatitis B Patients
por: Xu, Xueying, et al.
Publicado: (2021)

Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
por: Wu, Cichun, et al.
Publicado: (2021)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study
por: Xu, Wei, et al.
Publicado: (2022)

Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection
por: Li, Qiang, et al.
Publicado: (2017)

Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ≤ 2 Upper Limit of Normal
por: Chen, Shanshan, et al.
Publicado: (2021)

Can GPR4 Be a Potential Therapeutic Target for COVID-19?
por: Yang, Li V., et al.
Publicado: (2021)

Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C
por: Arrayhani, Mohamed, et al.
Publicado: (2015)

The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease
por: Li, Qiang, et al.
Publicado: (2017)

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
por: Lee, Jia-Jung, et al.
Publicado: (2020)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19
por: Zhang, Jing, et al.
Publicado: (2022)

Characteristics of Peripheral Lymphocyte Subsets in Patients With Acute-On-Chronic Liver Failure Associated With Hepatitis B
por: Li, Juan, et al.
Publicado: (2021)

Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways
por: Zhang, Kun, et al.
Publicado: (2023)

Immunological Manifestations of Hepatitis E-Associated Acute and Chronic Liver Failure and Its Regulatory Mechanisms
por: Wu, Jian, et al.
Publicado: (2021)

Synovial Fibrosis Involvement in Osteoarthritis
por: Zhang, Li, et al.
Publicado: (2021)

Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
por: Paranaguá-Vezozzo, Denise C, et al.
Publicado: (2017)

Comparison between shear wave elastography and serological findings for the evaluation of fibrosis in chronic liver disease
por: Liaqat, Mahjabeen, et al.
Publicado: (2021)

The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: ‘The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa’ by Lemoine et al
por: Stockdale, Alexander J, et al.
Publicado: (2016)

Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
por: Wan, Minjie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jogn478ijb1utkgr9dec2itpi5